vimarsana.com

Latest Breaking News On - Larry biegelsen - Page 5 : vimarsana.com

NovoCure (NVCR) Q4 2023 Earnings Call Transcript

NVCR earnings call for the period ending December 31, 2023.

United statesNew yorkLarry biegelsenOptune gioJonathan chang leerinkJonathan changVijay kumarDavid tranJanice armbrustEmily bodnarJason bednar piper sandlerOptune gio temozolomideJason bednarNicolas leupinAshley cordovaFrank leonard

Nevro Corp (NYSE:NVRO) Q4 2023 Earnings Call Transcript

Nevro Corp. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.5. Nevro Corp.

Costa ricaCanaccord genuityAdam maederKevin thornalJoanne wuenschAngie mccabeBrandon vazquezShagun singhPiper sandlerGreg sillerNathan treybeckKallum titchmarshRichard newitterLarry biegelsenWilliam blairAnthony petrone

NovoCure (NVCR) Q4 2023 Earnings Call Transcript

NVCR earnings call for the period ending December 31, 2023.

United statesNew yorkJason bednar piper sandlerOptune gioNicolas leupinEmily bodnarJason bednarVijay kumarIngrid goldbergAshley cordovaFrank leonardJonathan changPiper sandlerJanice armbrustOptune luaOptune gio temozolomide

Medtronic Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street s Most Accurate Analysts

Medtronic plc (NYSE:MDT) is expected to release earnings results for its third quarter of fiscal year 2024, before the opening bell on Feb. 20, 20.

Matthew taylorRichard newitterRick wiseLarry biegelsenSteven lichtmanWells fargoSimplera syncBrain stimulationAnalyst stock ratings

Medtronic Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street s Most Accurate Analysts - Medtronic (NYSE:MDT)

Medtronic plc (NYSE: MDT) is expected to release earnings results for its third quarter of fiscal year 2024, before the opening bell on Feb. 20, 2024.

Richard newitterMatthew taylorLarry biegelsenRick wiseSteven lichtmanWells fargoSimplera syncBrain stimulationAnalyst stock ratings

vimarsana © 2020. All Rights Reserved.